Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    17087947 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)
Condition: Colorectal Adenoma
Interventions: Drug: MK0966; Rofecoxib / Duration of Treatment: 156 weeks;   Drug: Placebo/ Duration of Treatment: 156 weeks
2 Completed Lipid Efficacy/Tolerability Study (0524A-020)
Conditions: Primary Hypercholesterolaemia;   Mixed Hyperlipidaemia
Interventions: Drug: niacin (+) laropiprant;   Drug: ER-niacin

Study has passed its completion date and status has not been verified in more than two years.